Circadin 2mg Prolonged-release tablet.
PDF Leaflet Revision Date: 15 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of primary insomnia in patients aged 55 and over.
Dosage (summary)
2 mg once daily, 1-2 hours before bedtime after food.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation; safety not established.
Key Drug Interactions
- Fluvoxamine increases melatonin levels
- Cimetidine increases melatonin levels
- Alcohol reduces effectiveness
Contraindications
- Hypersensitivity to melatonin or excipients
- Pregnancy and lactation
Common side effects
- Headache
- Nasopharyngitis
- Back pain
- Arthralgia
Counselling Points
- Take 1-2 hours before bedtime.
- Do not crush or chew tablets.
- Avoid alcohol while taking this medication.
Serious warnings
- May cause drowsiness; caution with hazardous activities.
- Not recommended for autoimmune diseases.
Important Disclaimer
The Circadin 2mg Prolonged-release tablet. professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
